About this Research Topic
Global food allergy has increased greatly over the past few decades, with approximately 220 million individuals having at least one diagnosis. While the default prognosis is allergen avoidance, ongoing research suggests that oral immunotherapy can be effective in helping patients reach desensitization.
This Research Topic aims to explore oral immunotherapy (OIT), the process by which patients ingest gradually increasing amounts of their food allergen. Specifically, this Research Topic will investigate safety efficacy, adjunct therapy, patient-reported outcomes like quality of life, and future applications.
Below examples are suitable themes for manuscripts:
• The impact of OIT on quality of life
• Single- and multi-allergen OIT
• Maintaining desensitization after OIT
• Assessing adverse events in OIT
• Eosinophilic esophagitis and OIT
• Adjuvant therapies with OIT
This Research Topic aims to explore oral immunotherapy (OIT), the process by which patients ingest gradually increasing amounts of their food allergen. Specifically, this Research Topic will investigate safety efficacy, adjunct therapy, patient-reported outcomes like quality of life, and future applications.
Below examples are suitable themes for manuscripts:
• The impact of OIT on quality of life
• Single- and multi-allergen OIT
• Maintaining desensitization after OIT
• Assessing adverse events in OIT
• Eosinophilic esophagitis and OIT
• Adjuvant therapies with OIT
Keywords: Oral immunotherapy, oral food challenge, desensitization, long-term tolerance, IgE, sustained unresponsiveness, anaphylaxis, food allergy, omalizumab, dupilumab
Important Note: All contributions to this Research Topic must be within the scope of the section and journal to which they are submitted, as defined in their mission statements. Frontiers reserves the right to guide an out-of-scope manuscript to a more suitable section or journal at any stage of peer review.
